Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
U287598-10mg
|
10mg |
3
|
$13.90
|
|
|
U287598-100mg
|
100mg |
3
|
$33.90
|
|
|
U287598-250mg
|
250mg |
3
|
$66.90
|
|
|
U287598-1g
|
1g |
2
|
$166.90
|
|
|
U287598-5g
|
5g |
3
|
$533.90
|
|
|
U287598-25g
|
25g |
2
|
$1,666.90
|
|
PI 3-K/Akt/mTOR signaling inhibitor; blocks phosphorylation of Akt and p70S6Kin vitro
| Synonyms | 3,8-Dihydroxyurolithin | 3,8-dihydroxy-urolithin | FT-0778244 | 3,8-dihydroxy-6h-dibenzo[b,d]pyran-6-one | 3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one | CHEBI:168442 | 6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy- | A901528 | AC-31959 | ILJ8NEF6DT | SY070232 | |
|---|---|
| Specifications & Purity | ≥98%(HPLC) |
| Biochemical and Physiological Mechanisms | PI 3-K/Akt/mTOR signaling pathway inhibitor; blocks phosphorylation of Akt and p70S6K in pancreatic ductal adenocarcinoma (PDAC). Inhibits proliferation and migration and promotes apoptosis of PDAC cell linesin vitro(IC50values are 10.23 - 62.28 μM). Supp |
| Storage Temp | Store at -20°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Phenylpropanoids and polyketides |
| Class | Coumarins and derivatives |
| Subclass | Not available |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Coumarins and derivatives |
| Alternative Parents | Isocoumarins and derivatives 2-benzopyrans 1-benzopyrans Pyranones and derivatives 1-hydroxy-2-unsubstituted benzenoids Heteroaromatic compounds Lactones Oxacyclic compounds Organooxygen compounds Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Coumarin - Isocoumarin - Benzopyran - 1-benzopyran - 2-benzopyran - 1-hydroxy-2-unsubstituted benzenoid - Pyranone - Pyran - Benzenoid - Heteroaromatic compound - Lactone - Oxacycle - Organoheterocyclic compound - Organooxygen compound - Hydrocarbon derivative - Organic oxide - Organic oxygen compound - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as coumarins and derivatives. These are polycyclic aromatic compounds containing a 1-benzopyran moiety with a ketone group at the C2 carbon atom (1-benzopyran-2-one). |
| External Descriptors | Not available |
|
|
|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Pubchem Sid | 504763884 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504763884 |
| IUPAC Name | 3,8-dihydroxybenzo[c]chromen-6-one |
| INCHI | InChI=1S/C13H8O4/c14-7-1-3-9-10-4-2-8(15)6-12(10)17-13(16)11(9)5-7/h1-6,14-15H |
| InChIKey | RIUPLDUFZCXCHM-UHFFFAOYSA-N |
| Smiles | C1=CC2=C(C=C1O)C(=O)OC3=C2C=CC(=C3)O |
| Isomeric SMILES | C1=CC2=C(C=C1O)C(=O)OC3=C2C=CC(=C3)O |
| PubChem CID | 5488186 |
| Molecular Weight | 228.20 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jan 13, 2025 | U287598 | |
| Certificate of Analysis | Jan 13, 2025 | U287598 | |
| Certificate of Analysis | Jan 13, 2025 | U287598 | |
| Certificate of Analysis | Jan 13, 2025 | U287598 | |
| Certificate of Analysis | Jan 13, 2025 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Oct 19, 2022 | U287598 | |
| Certificate of Analysis | Jun 21, 2022 | U287598 | |
| Certificate of Analysis | Jun 20, 2022 | U287598 |
| Solubility | Solvent:DMSO, Max Conc. mg/mL: 22.82, Max Conc. mM: 100 |
|---|---|
| Molecular Weight | 228.200 g/mol |
| XLogP3 | 2.300 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 228.042 Da |
| Monoisotopic Mass | 228.042 Da |
| Topological Polar Surface Area | 66.800 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 317.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
Starting at $252.90
| 1. Yang Yang, Pui-Kei Lee, Ho-Ching Wong, Danyue Zhao. (2024) Oral supplementation of Gordonibacter urolithinfaciens promotes ellagic acid metabolism and urolithin bioavailability in mice. FOOD CHEMISTRY, 437 (137953). |
| 2. Zeyuan Jin, Yaqi Zhang, Haijun Hu, Qian Li, Liwen Zhang, Kefei Zhao, Wenxing Liu, Lanjuan Li, Changyou Gao. (2024) Closed-Loop Theranostic Microgels for Immune Microenvironment Modulation and Microbiota Remodeling in Ulcerative Colitis. BIOMATERIALS, (122834). |
| 3. Huang Zhengyuan, Ren Zhongyu, Wang Sanwang, Xiao Ling, Ling Yipeng, Xie Yinping, Wang Gaohua, Zhou Benhong. (2025) Urolithin A alleviates schizophrenic-like behaviors and cognitive impairment in rats through modulation of neuroinflammation, neurogenesis, and synaptic plasticity. Scientific Reports, 15 (1): (1-15). |
| 4. Zhengyuan Huang, Guanghui Chen, Zhongyu Ren, Ling Xiao, Ziyue Chen, Yinping Xie, Gaohua Wang, Benhong Zhou. (2025) Urolithin A ameliorates schizophrenia-like behaviors and cognitive impairments in female rats by modulating NLRP3 signaling. INTERNATIONAL IMMUNOPHARMACOLOGY, 151 (114336). |